Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
However, those benefits come at a significant financial cost, with annual treatment expenses typically ranging from $12,000 to $16,000 per patient. GLP1 coverage is one of the most consequential benefit decisions employers will face in 2026
TRIUMPH-1 Phase 3 Trial Results and Clinical Trial Insights On May 21, 2026, Eli Lilly revealed the promising results of its TRIUMPH-1 Phase 3 trials for Retatrutide
Tirzepatide performs measurably better here
Worked examples for 40 units at each concentration Example 1: 40 units from a 1 mg/mL vial (40 / 100) x 1 = 0.4 x 1 = 0.4 mg This is well below a typical therapeutic dose for weight management
US$ 22.09
US$ 22.24
US$ 28.40
US$ 21.66
